Clinical Trial Detail

NCT ID NCT03278379
Title Avelumab in G2-3 NET (NET-002)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sunnybrook Health Sciences Centre
Indications

gastrointestinal neuroendocrine tumor

pulmonary neuroendocrine tumor

Therapies

Avelumab

Age Groups: senior adult

No variant requirements are available.